Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gelteq (GELS) Common Equity (2023 - 2025)

Gelteq has reported Common Equity over the past 3 years, most recently at $10.1 million for Q2 2025.

  • For Q2 2025, Common Equity rose 1.63% year-over-year to $10.1 million; the TTM value through Jun 2025 reached $10.1 million, up 1.63%, while the annual FY2025 figure was $10.1 million, 1.63% up from the prior year.
  • Common Equity for Q2 2025 was $10.1 million at Gelteq, down from $12.3 million in the prior quarter.
  • Over five years, Common Equity peaked at $12.5 million in Q2 2023 and troughed at $10.0 million in Q2 2024.
  • A 3-year average of $11.2 million and a median of $11.2 million in 2024 define the central range for Common Equity.
  • Biggest five-year swings in Common Equity: fell 20.14% in 2024 and later increased 1.63% in 2025.
  • Year by year, Common Equity stood at $12.5 million in 2023, then dropped by 1.45% to $12.3 million in 2024, then decreased by 17.64% to $10.1 million in 2025.
  • Business Quant data shows Common Equity for GELS at $10.1 million in Q2 2025, $12.3 million in Q4 2024, and $10.0 million in Q2 2024.